Shares outstanding increased 63.6%
Shares outstanding changed +63.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Shares outstanding changed +63.6% from the comparable as-filed period. The change ranks at the 100th percentile of 8 prior comparable changes.
Operating margin changed -12916 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross margin changed +329 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed -74.2% from the comparable as-filed period.
Cash & equivalents changed +50.7% from the comparable as-filed period.
Free-cash-flow proxy changed -158.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Operating income changed -12.2% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross profit changed -64.6% from the comparable as-filed period.
Total assets changed -32.2% from the comparable as-filed period.
Trade receivables changed -75.2% from the comparable as-filed period.
Working capital changed -38.5% from the comparable as-filed period.
Current assets changed -32.5% from the comparable as-filed period.
Inventory / revenue changed +32787 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash flow changed -157.8% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change. This reverses 3 consecutive comparable moves in the opposite direction.
Short-term borrowings changed -36.6% from the comparable as-filed period.
SBC / revenue changed +3338 basis points from the comparable as-filed period.
Current liabilities changed -25.2% from the comparable as-filed period.
Stock-based compensation changed +26.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Working capital / assets changed -421 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory changed -24.1% from the comparable as-filed period.
Operating cash-flow margin changed -8194 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow margin changed -8234 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
R&D / revenue changed +2872 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -373 basis points from the comparable as-filed period.
Research & development changed -9.0% from the comparable as-filed period.
Capex / revenue changed +40 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current ratio changed -9.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed +0.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.